Health ❯ Healthcare ❯ Neurology

Neurological Disorders

Parkinson's Disease Alzheimer's Disease Epilepsy Brain Implants ALS Awareness Cerebral Adrenoleukodystrophy (CALD) Spinal Stenosis Hearing Disorders Dr. Oliver Sacks Respiratory Issues

3 ARTICLES

last mo.

Sanofi Stops MOBILIZE Phase 3 Trial of Riliprubart in CIDP After Futility Finding

An independent data monitoring committee concluded the study was unlikely to show sufficient efficacy, a result that will shape whether Sanofi advances other riliprubart trials.

9 ARTICLES

last mo.

World Multiple Sclerosis Day Puts Spotlight on Treatment Shortfalls in Latin America

3 ARTICLES

2mo ago

FDA Grants Accelerated Approval to Avlayah for Neurologic Manifestations of Hunter Syndrome

3 ARTICLES

4mo ago

CSF Enzyme Marker Distinguishes Parkinson’s and Lewy Body Dementia From Alzheimer’s

6 ARTICLES

4mo ago

Vincristine Detected in Spinal Fluid After Leukemia Injections at Saitama Prefectural Children’s Medical Center

3 ARTICLES

5mo ago

EU Regulators Recommend EU-Wide Withdrawal of Levamisole Medicines Over Brain Risk

4 ARTICLES

5mo ago

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

3 ARTICLES

7mo ago

USC Team Maps Four Hidden Neuron Layers in Mouse Hippocampal CA1

3 ARTICLES

8mo ago

Tohoku University Team to Launch Investigator-Led Trial of New Mitochondrial Disease Drug in December

3 ARTICLES

9mo ago

World Stroke Day Spotlights Care Gaps as Trial Finds Structured Aftercare Cuts One‑Year Deaths

3 ARTICLES

10mo ago

Cryo-EM Study Reveals Gephyrin Filaments as the Scaffold of Inhibitory Synapses

5 ARTICLES

10mo ago

Double-Blind Trial Confirms Shunt Surgery Improves Gait in Older Adults With Normal-Pressure Hydrocephalus

3 ARTICLES

11mo ago

Kennedy Krieger Review Maps Biomarkers to Earlier Sturge-Weber Care, Paving Way for Trials

3 ARTICLES

last yr.

Study Rules Out Mystery Brain Disease in New Brunswick, Citing Misdiagnoses

10 ARTICLES

last yr.

Study Finds No Evidence of Mystery Brain Disease in New Brunswick

3 ARTICLES

last yr.

New Brain-Mapping Tool START Unveiled by Salk Scientists

Neurological Disorders

Sanofi Stops MOBILIZE Phase 3 Trial of Riliprubart in CIDP After Futility Finding

World Multiple Sclerosis Day Puts Spotlight on Treatment Shortfalls in Latin America

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

Roche Files MS Drug Fenebrutinib With Regulators Despite Trial Deaths

World Parkinson’s Day Shifts Focus to Early, Often Silent Signs

Parkinson’s Burden Climbs Worldwide as New Treatments Advance

FDA Grants Accelerated Approval to Avlayah for Neurologic Manifestations of Hunter Syndrome

CSF Enzyme Marker Distinguishes Parkinson’s and Lewy Body Dementia From Alzheimer’s

Vincristine Detected in Spinal Fluid After Leukemia Injections at Saitama Prefectural Children’s Medical Center

EU Regulators Recommend EU-Wide Withdrawal of Levamisole Medicines Over Brain Risk

Never miss stories about

Neurological Disorders

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

USC Team Maps Four Hidden Neuron Layers in Mouse Hippocampal CA1

Tohoku University Team to Launch Investigator-Led Trial of New Mitochondrial Disease Drug in December

World Stroke Day Spotlights Care Gaps as Trial Finds Structured Aftercare Cuts One‑Year Deaths

Cryo-EM Study Reveals Gephyrin Filaments as the Scaffold of Inhibitory Synapses

Double-Blind Trial Confirms Shunt Surgery Improves Gait in Older Adults With Normal-Pressure Hydrocephalus

Kennedy Krieger Review Maps Biomarkers to Earlier Sturge-Weber Care, Paving Way for Trials

Study Rules Out Mystery Brain Disease in New Brunswick, Citing Misdiagnoses

Study Finds No Evidence of Mystery Brain Disease in New Brunswick

New Brain-Mapping Tool START Unveiled by Salk Scientists

Never miss stories about

Neurological Disorders